Pharmafile Logo
Pharmafocus logo
Advanced Search

Medical Communications

Showing 15 posts of 6411 posts found.

karl_ludwig_kley

Merck chief executive Karl-Ludwig Kley to step down in April

March 9, 2016 Medical Communications, Research and Development Denreon, Karl-Ludwig Kley, Merck, karl ludwig kley

 It has been announced that Karl-Ludwig Kley, chief executive officer at Merck, will step down from his position at the …
Appointment
biotrial_facility_rennes

French clinical trial tragedy “astonishing and unprecedented”, says report

March 9, 2016 Medical Communications, Research and Development Bial, Biotrial, France, clinical trial, death, rennes, tragedy

A report into the clinical trial tragedy in France in January has called the event “astonishing and unprecedented” but did …
News
merckincweb2

MSD joins charity-industry partnership Dementia Consortium

March 9, 2016 Medical Communications, Research and Development MSD, alzheimer's society, dementia, dementia consortium

The Dementia Consortium has welcomed MSD into the fold as a new partner in its global venture to accelerate drug …
News
sanofi_pasteur_msd

Sanofi Pasteur and MSD end European vaccines partnership

March 8, 2016 Medical Communications, Research and Development, Sales and Marketing MSD, Sanofi Pasteur, Sanofi pasteur msd, vaccines

Sanofi Pasteur and MSD have announced that they will end their joint vaccines operations in Europe, bringing an end to …
News
dr_virginia_jamieson_

Kuros Biosciences re-appoints chief medical officer

March 8, 2016 Medical Communications

Kuros Biosciences has announced the appointment of Dr Virginia Jamieson as chief medical officer and member of the executive board …
Appointment
bms

BMS criticises Scottish regulator over Opdivo skin cancer ‘no’

March 7, 2016 Medical Communications, Research and Development Bristol-Myers Sqibb, NICE, SMC, melanoma, opdivo

Bristol-Myers Squibb says the Scottish Medicines Consortium’s (SMC) decision not to recommend its immunotherapy Opdivo (nivolumab) as a monotherapy for …
News
teva_copy

Teva suffers EpiPen generic setback after FDA rejection

March 4, 2016 Medical Communications, Research and Development FDA, Teva, analphylaxis, approval, auto injector, auto-injector, rejection

The release of Teva Pharmaceuticals generic for the anaphylaxis treatment, EpiPen (epinephrine), is now expected to be severely delayed after …
News
rd_hands

BioMarin reports positive early-stage results for trial drug to treat CLN2 disease

March 4, 2016 Medical Communications

Biotechnology firm BioMarin Pharmaceutical has announced positive results from early stage trial for drug to treat neurodegenerative disease in children.  …
News
merck_logo_blue_rgb

Merck & Pfizer tie-up with Verastem to develop ovarian cancer drug

March 4, 2016 Medical Communications

German drug major Merck along with Pfizer has joined forces with Verastem to develop the trial drug candidate avelumab to …
News
sanofi_logo_vertical_2011_4colors

Sanofi Genzyme present positive Phase 2 results for fatal neuromuscular disease treatment

March 4, 2016 Medical Communications, Research and Development Pompe disease, Sanofi, clinical trial, neuromuscular, phase 2

Sanofi Genzyme, the branch of the French-based pharma company that focuses on diseases difficult to diagnose and treat, have published …
News
magic_bullets_pills

Almost half of US physicians will prescribe more biosimilars, according to survey

March 4, 2016 Medical Communications Obama, US, biosimilar, patent, prescribing

New data published by InCrowd has suggested that US physicians are very amenable to the prescription of biosimilars, with some …
News
ucb_logo_and_chief_executive

UCB targets regulatory filing for its osteoporosis drug in 2016

March 3, 2016 Medical Communications, Research and Development, Sales and Marketing Romosozumab, UCB Pharma, osteoporosis

Belgian drug company UCB says it is looking at a regulatory filing for its trial drug romosozumab to treat osteoporosis …
News
deb_jorn

Valeant company group chairman and executive vice president resigns

March 3, 2016 Medical Communications, Sales and Marketing Valeant, appointed, resignation

In an already troubled week for Valeant Pharmaceuticals, the company has now announced that its group chairman and executive vice …
Appointment
nda_group_appointment

Bill Griffiths joins NDA group as general manager UK

March 2, 2016 Medical Communications NDA Group

Industry veteran Bill Griffiths has joined NDA Group to head up the company’s UK consulting team and NDA’s advisory board.  …
Appointment

LEO Pharma UK/Ireland appoints new dermatology director

March 2, 2016 Medical Communications, Sales and Marketing

LEO Pharma has appointed Michael Hinchy as dermatology director with responsibility for its UK/Ireland affiliate. Michael brings over 16 years …
Appointment
The Gateway to Local Adoption Series

Latest content

Closing the immunisation gap: partnership working that delivered at scale

June 5, 2026

Phase 2 study explores imaging approach for interstitial lung disease

June 5, 2026

Laverock secures funding for gene-control platform development

June 4, 2026

LifeArc and Elpida partner to advance gene therapies for ultra-rare childhood diseases

June 3, 2026

Well Pharmacy and Alzheimer’s Society launch dementia partnership

June 2, 2026